World Genetic Testing Market

World Genetic Testing Market

This report analyzes the worldwide markets for Genetic Testing in Millions of US$. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, and Rest of World. Annual forecasts are provided for each region for the period of 2000 through 2015. The report profiles 79 companies including many key and niche players worldwide such as Abbott Laboratories, Abbott Molecular Inc., Applied Biosystems Inc., AutoGenomics, Inc., BioRad Laboratories, Celera Group, Clinical Data, Inc., Genzyme Genetics, Orchid Cellmark, Inc., PerkinElmer, Inc., Quest Diagnostics, Inc., Roche Diagnostics, Corp., Roche Molecular Diagnostics Inc., and Sciona Ltd. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

GENETIC TESTING MCP-1392
A GLOBAL STRATEGIC BUSINESS REPORT


CONTENTS


I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-2
Quantitative Techniques & Analytics I-3
Product Definitions and Scope of Study I-3
Prenatal Diagnosis I-3
Newborn Screening I-3
Pharmacogenetics/Pharmacogenomics I-3
Predictive Testing I-4


II. EXECUTIVE SUMMARY

1. Overview II-1
Progressing from Service Driven to Product-Driven Market II-1
Genetic Testing Outlook Brightens II-1
Issues & Trends Affecting the Market II-1
Challenges Faced II-1
Online Approach Gains Momentum II-2
Recommendations of ACOG and ACGM Augments Demand for CF Testing II-2
Ethical Issues & Need for Appropriate Regulating Policies II-3
Routine Clinical Testing Vs. Predictive Genetic Testing II-3
Issues Related to Genetic Tests for Obesity II-4
Competition II-4
Table 1: Leading Players in the Worldwide Genetic Testing
Market (2005): Percentage Breakdown by Value Sales for Roche
Diagnostics / Affymetrix, Abbott Laboratories, Bio-Rad
Laboratories, and Others (includes corresponding Graph/Chart) II-4

2. Product Overview II-5
Preface to Genetic Testing II-5
Genetic Testing and its Applications II-5
Gene Candidate and Genome Screen II-6
‘DNA Chip’ to Chip into Genetic Field II-6
Techniques Used to Identify Changes in Genes II-6
Types of Genetic Testing II-7
Steps in Genetic Testing Process II-8
Limitations II-9
Risks and Other Limitations of Genetic Testing II-9
Medical Institutions to Reap the Benefits of Genetic Testing II-9
Pharmacogenetics/Pharmacogenomics II-9
Review of Select Genetic Tests II-10
Cystic Fibrosis II-10
Breast and Ovarian Cancer II-10
Alzheimer's Disease II-10
Colorectal Cancer II-10
Haemochromatosis (HH) II-10
Cowden Syndrome II-11
Huntington's Disease II-11
Costs of Select Tests II-11
Table 2: Costs of Select Genetic Tests (includes
corresponding Graph/Chart) II-11

3. Product Launches II-12
Clinical Data Introduces Genetic Test for HCM II-12
Iverson Genetic Diagnostics Unveils Warfarin Sensitivity Tests II-12
HairDX Unveils New Test for Predicting Female Hair Loss II-12
HairDX Introduces Genetic Test for Male Baldness II-12
Clinical Data Introduces Pharmacogenetic Test for Clozapine II-13
Seegene Launches 18-Plex Genotyping Test II-13
InterGenetics Introduces Onco Vue II-13
Applied Biosystems Introduces Novel DNA Technologies II-14
Dabur Introduces CML Quest II-14
deCODE Launches deCODE T2 II-14
DNAPrint Announces the Launch of Ancestry Indicator II-14
Genzyme Unveils New Mutation Analysis Test II-15
Orchid BioSciences Introduces New Testing Kit II-15
Focus Diagnostics Introduces GenomEx(TM) Service II-15
Relative Genetics Introduces Y-chromosome haplogroup Service
on Web Site II-15
Genzyme Unveils Upgraded CFplus Cystic Fibrosis (CF) Mutation
Analysis II-15
TMC Introduces AJP II-16
Genaissance Rolls Out FAMILION Test II-16
Tm Bioscience Rolls Out Tag-It Mutation Detection Kits II-16

4. Recent Industry Activity II-17
Pfizer Animal Health to Take Over Bovigen and Catapult Genetics II-17
DNA Testing Systems Inks Agreement with DNAPrint Genomics II-17
PerkinElmer Acquires Newborn Metabolic Screening Assets of
Pediatrix II-17
Hologic Acquires Third Wave II-17
Dako Denmark Receives FDA Approval for TOP2A FISH pharmDx Device II-18
Abbott Partners with Roche, OSI and Genentech II-18
Lab21 Partners with Amgen II-18
Medical Solutions Acquires Autogen Bioclear II-19
Nanobac to Acquire DNAPrint Genomics II-19
HairDX and Bosley Join Hands for Offering Genetic Test for
Baldness II-19
Nioxin Inks Agreement with HairDX II-20
Orchid Cellmark Acquires ReliaGene Technologies II-20
Celera Takes Over Atria Genetics II-20
Roche Acquires 454 Life Sciences II-20
BioServe and DNAPrint Genomics Form Strategic Alliance II-21
Gentris Divests Stake in Genetic Testing Unit II-21
LabCorp Announces Genetic Test Partnership for Bucindolol
Prescription II-21
Newsham Genetics Takes Over Monsanto Choice Genetics II-21
BioServe Takes Over Genomics Collaborative II-22
CytoDyn Completes Acquisition of Advanced Genetic Technologies II-22
Sorenson Genomics Takes Over Identigene II-22
Clinical Data Enters into a License Agreement with VCGS II-22
Clinical Data Collaborates with George Washington University II-23
Luminex Takes Over TM Bioscience II-23
Schering-Plough Enters into a Contract with Warnex II-23
Cepheid Acquires Sangtec II-24
Medco Collaborates with Mayo II-24
Lab21 to Offer CLDA’s Genetic Test for Cardiac Channelopathy II-24
Clinical Data Pockets Epidauros Biotechnologie II-24
Beijing Adinovo Gene and GENDIA Ink Genetic Test Exchange
Agreement II-25
Genetic Technologies Forms Alliance with UTEK II-25
QIAGEN Acquires Digene II-25
Luminex Inks Development Licensing Agreement with Mayo Clinic II-25
Manipal Joins Hands with NorDiag II-26
Orchid BioSceinces Enters into an Agreement with Prion
Diagnostica II-26
DNAPrint™ genomics to Purchase Ellipsis II-26
Tm Bioscience Inks a Pact with Maxxam Analytics II-26
DNAPrint genomics Takes Over Trace Genetics II-27
Roche Diagnostics Inks a Licensing Agreement with Innogenetics II-27
Clinical Data Purchases Genaissance Pharmaceuticals II-27
Illumina Pockets CyVera Corporation II-27
Orchid Cellmark Inks Contract with Merial II-27
Sequenom Gains Noninvasive Prenatal Diagnostic IP Rights from
Isis II-27
TMC Inks a Pact with ARUP Laboratories II-28
Specialty Laboratories Accords with Roche II-28
TMC Ceases Licensing Agreement with Abbott II-28
Correlagen Diagnostics Collaborates with Children's Hospital
Boston II-28
Edith Cowan University Strikes Deal with Solbec II-28
InterGenetics Join Hands with i.d.e.a.s. II-28
Clinical Data Acquires Icoria II-29
SomaLogic Strikes a Deal with Quest Diagnostics II-29
DNAPrint Bags Grant from the Federal Government II-29
Tepnel Acquires Orchid’s Diagnostic Unit II-29
Lark Tech. Merges with Genaissance II-29
PRF in Alliance with Sydney Biotech II-29
Osmetech and LGC Sign Licensing Pact II-30
TMC Signs a Pact with LabOne II-30
Abbott in Agreement with Atria II-30
Third Wave Grants Marketing and Distribution Rights to
Innogenetics II-30
Orchid Bags Deal to Provide Testing Services to Immigrants to
New Zealand II-30
Tm Bioscience Contracts with Pharmacogenetics II-31
Genetic Technologies Grants License to Genzyme II-31
New Genetic Testing Identifies Gene Responsible for Alzheimer
Disease II-31
Roche Licenses GeneChip® Technology from Affymetrix II-31
Genaissance Acquires DNA Sciences II-31
GTG Joins GENDIA Diagnostic Genetic Testing Network II-31
Arch Collaborates with GeneLink to Market Formulations II-32
Roche Diagnostics and GIS to Develop SARS Detection Kit II-32
Roche Diagnostics in Agreement with Innogenetics II-32
Cenetron in Alliance with Roche Diagnostics II-32
Gribbles Establishes Gribbles Molecular Science, a New Genetic
Testing Firm II-32
Roche the First to Receive Clearance for Thrombophilia Genetic
Disorder Tests II-33
Roche and DeCode Develop DNA-based Tests to Foretell Behavior II-33
Roche and deCODE Discover Changes in Gene Responsible for
Osteoporosis II-33
Roche and deCODE Announce Discovery of New Gene Structures II-33
Mayo Contracts with Tm Bioscience II-33

5. Technological Developments - Recent Past data II-34
New Molecular Diagnostic device to Improve Genetic Tests for
Alzheimer disease II-34
Deakin Clinic Offers PGD, a Sophisticated Testing for Genetic
Disorders II-34
New Gene Mapping Method to Enhance Identification of Haplotype
Block II-34
New Non-Invasive test a Better Indicator of Malignancy than
the PSA Test II-34

6. Focus on Select Global Players II-35
Abbott Laboratories (USA) II-35
Abbott Molecular Inc. (USA) II-35
Applied Biosystems Inc. (USA) II-35
AutoGenomics, Inc. (USA) II-35
BioRad Laboratories (USA) II-36
Celera Group (USA) II-36
Clinical Data, Inc. (USA) II-36
Genzyme Genetics (USA) II-36
Orchid Cellmark, Inc (USA) II-37
PerkinElmer Inc., (USA) II-37
Quest Diagnostics, Inc. (USA) II-37
Roche Diagnostics, Corp. (Switzerland) II-38
Roche Molecular Diagnostics Inc. (USA) II-38
Sciona, Limited. (USA) II-38

7. Global Market Perspective II-39
Table 3: World Recent Past, Current & Future Market Analysis
for Genetic Testing by Geographic Region - US, Canada,Japan,
Europe and Rest of World Independently Analyzedwith Annual
Sales Figures in US$ Million for Years 2000 through 2010
(includes corresponding Graph/Chart) II-39

Table 4: World long-term projections for Genetic Testing by
Geographic Region - US, Canada,Japan, Europe and Rest of World
Independently Analyzedwith Annual Sales Figures in US$ Million
for Years 2011through 2015 (includes corresponding
Graph/Chart) II-40

Table 5: World 10-Year Perspective for Genetic Testing by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Canada, Japan, Europe and Rest of World Markets for Years
2003, 2008 & 2012 (includes corresponding Graph/Chart) II-41


III. MARKET

1. The United States III-1
A.Market Analysis III-1
Current and Future Analysis III-1
Newborn Testing Gain Ground III-1
Table 6: US Prenatal and Newborn Genetic Testing Market
(2000-2005): Annual Sales in US$ Million (includes
corresponding Graph/Chart) III-1
Predictive Screening -Another Growth Area III-2
Direct-to-Consumer Testing- A Growing Market III-2
US Regulatory Environment III-2
Genetic Testing Set for Big Boost with New Legislation III-3
DNA-Based Testing to Move Beyond Research Laboratories III-3
Key and Emerging Players in US III-3
Abbott Laboratories III-3
Abbott Molecular Inc. III-4
Applied Biosystems Inc. III-4
AutoGenomics, Inc. III-4
BioRad Laboratories III-4
Celera Group III-5
Clinical Data, Inc. III-5
Genova Diagnostics III-5
Genzyme Genetics III-6
InterGenetics III-6
Myriad Genetic Laboratories, Inc. III-6
Nanogen, Inc. III-6
Orchid Cellmark, Inc III-7
PerkinElmer, Inc III-7
Quest Diagnostics, Inc. III-7
Roche Molecular Diagnostics Inc. III-8
Sciona, Limited. III-8
Product Launches III-8
Strategic Developments III-12
B.Market Analytics III-23
Table 7: US Recent Past, Current & Future Analysis for
Genetic Testing by Segment-Pharmacogenomic Testing, Prenatal
and Newborn Genetic Testing, and Predictive Medicine Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) III-23

Table 8: US Long-term Projections for Genetic Testing by
Segment-Pharmacogenomic Testing, Prenatal and Newborn
Genetic Testing, and Predictive Medicine Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2011 through 2015 (includes corresponding
Graph/Chart) III-23

Table 9: US 10-Year Perspective for Genetic Testing by
Segment-Pharmacogenomic Testing, Prenatal and Newborn
Genetic Testing, and Predictive Medicine Markets for 2003,
2008 & 2012 (includes corresponding Graph/Chart) III-24

2. Canada III-25
A.Market Analysis III-25
Canada, the Market to be Watched Out for III-25
Key Player III-25
Luminex Molecular Diagnostics III-25
Product Launches III-25
Strategic Developments III-26
B.Market Analytics III-27
Table 10: Canadian Recent Past, Current & Future Analysis
for Genetic Testing - Annual Sales Figures in US$ Million
for Years 2000 through 2010 (includes corresponding
Graph/Chart) III-27

Table 11: Canadian Long-term Projections for Genetic Testing
- Annual Sales Figures with Annual Sales Figures in US$
Million for Years 2011 through 2015 (includes corresponding
Graph/Chart) III-28

3. Japan III-29
Market Analysis III-29
Table 12: Japanese Recent Past, Current & Future Analysis
for Genetic Testing - Annual Sales Figures in US$ Million
for Years 2000 through 2010 (includes corresponding
Graph/Chart). III-29

Table 13: Japanese Long-term Projections for Genetic
Testing - Annual Sales Figures with Annual Sales Figures in
US$ Million for Years 2011 through 2015 (includes
corresponding Graph/Chart) III-30

4. Europe III-31
A.Market Analysis III-31
A Brief Overview of Legislations/Regulatory Policies in
Select European Countries III-31
Government Encourages Genetic Testing in UK III-31
Key and Emerging Players in Europe III-32
Biotage AB (Sweden) III-32
IMGM Laboratories GmbH (Germany) III-33
Roche Diagnostics, Corp. (Switzerland) III-33
Strategic Developments III-33
B.Market Analytics III-39
Table 14: European Recent Past, Current & Future Analysis
for Genetic Testing - Annual Sales Figures in US$ Million
for Years 2000 through 2010 (includes corresponding
Graph/Chart). III-39

Table 15: European Long-term Projections for Genetic Testing
- Annual Sales Figures with Annual Sales Figures in US$
Million for Years 2011 through 2015 (includes corresponding
Graph/Chart) III-39

5. Rest of World III-40
A.Market Analysis III-40
Asia & Latin America: The Future Markets for Genetic Testing III-40
Approval of Experiments on Human Embryos in New Zealand III-40
Singapore Sets Guidelines for Genetic Research and Testing III-40
Product Launches III-41
Strategic Developments III-41
B.Market Analytics III-42
Table 16: Rest of World market for Genetic Testing - Recent
Past, Current & Future Analysis with Annual Sales Figures
in US$ Million for Years 2000 through 2010 (includes
corresponding Graph/Chart) III-42

Table 17: Rest of World (*) Market for Genetic Testing
Long-term Projections with Annual Sales Figures in US$
Million for Years 2011 through 2015 (includes corresponding
Graph/Chart) III-43


IV. COMPETITIVE LANDSCAPE


-Abbott Laboratories (USA)
-Affiliated Genetics, Inc (USA)
-Affymetrix, Inc (USA)
-American Genetics, Inc (USA)
-Applied Biosystems Group (USA)
-Autogenomics, Inc (USA)
-Autoimmune Technologies LLC (USA)
-Becton, Dickinson & Company (USA)
-Biogenetic Services, Inc (USA)
-Bio-Rad Laboratories, Inc (USA)
-Bioscientia (Germany)
-Biotage AB (Sweden)
-BRT Laboratories, Inc (USA)
-Celera Diagnostics (USA)
-Columbia Laboratory Services (USA)
-Digene Corporation (USA)
-DNA Diagnostics Center (USA)
-DNAPrint Genomics, Inc (USA)
-Elan Corporation PLC (Ireland)
-Fujirebio Diagnostics, Inc (USA)
-Genaissance Pharmaceuticals, Inc (USA)
-Genecare Medical Genetics Center (USA)
-Genedx, Inc (USA)
-Genelex Corporation (USA)
-Genetest Corporation (USA)
-Genetic Profiles Laboratory (USA)
-Genetic Technologies, Inc (USA)
-Genetica DNA Laboratories, Inc (USA)
-Genetics & IVF Institute (USA)
-Genetree DNA Testing Center (USA)
-Genex Diagnostics Swabtest (USA)
-Genomic Health, Inc (USA)
-Genova Diagnostics (USA)
-Gentra Systems, Inc (USA)
-Genzyme Genetics (USA)
-Great Lakes Genetics, SC (USA)
-Gribbles Group Ltd (Australia)
-Healthcheck USA (USA)
-ID Labs Biotechnology (Canada)
-Identigene (USA)
-Identity Genetics, Inc (USA)
-IMGM Laboratories (Germany)
-Independent Forensics (USA)
-Innogenetics NV (Belgium)
-Intergenetics, Inc (USA)
-Interleukin Genetics, Inc (USA)
-Investigen, Inc (USA)
-Invitrogen Corporation (USA)
-Kimball Genetics, Inc (USA)
-Laboratory Corporation Of America Holdings (USA)
-Lark Technologies, Inc (USA)
-London Biosciences Corporation (UK)
-MDS Diagnostic Services (Canada)
-Myriad Genetics, Inc (USA)
-Nanogen, Inc (USA)
-Orchid Cellmark (USA)
-Osmetech, Inc Critical Care Division (USA)-Panomics, Inc (USA)
-Paragon Genetics™ (USA)
-Pediatrix Screening (USA)
-PerkinElmer, Inc (USA)
-Proactive Genetics, Inc (USA)
-PRO-DNA Diagnostic (Canada)
-Qiagen NV (The Netherlands)
-Quest Diagnostics, Inc (USA)
-Reliagene Technologies, Inc (USA)
-Roche Diagnostics (Switzerland)
-Sciona, Inc (USA)
-Sequenom, Inc (USA)
-St Josephs DNA Diagnostic Laboratories (USA)
-Tepnel Life Sciences PLC (UK)
-Third Wave Technologies, Inc (USA)
-TM Bioscience Corporation (Canada)
-Xtrana, Inc (USA)